BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 9142164)

  • 1. Sources of variability in mutant frequency determinations in different organs of lacZ plasmid-based transgenic mice: experimental features and statistical analysis.
    Boerrigter ME; Vijg J
    Environ Mol Mutagen; 1997; 29(3):221-9. PubMed ID: 9142164
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High sensitivity for color mutants in lacZ plasmid-based transgenic mice, as detected by positive selection.
    Boerrigter ME
    Environ Mol Mutagen; 1998; 32(2):148-54. PubMed ID: 9776177
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Background mutations and polymorphisms in lacZ-plasmid transgenic mice.
    Dollé ME; Snyder WK; van Orsouw NJ; Vijg J
    Environ Mol Mutagen; 1999; 34(2-3):112-20. PubMed ID: 10529734
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment of lacZ plasmid-based transgenic mice with benzo[a]pyrene: measurement of DNA adduct levels, mutant frequencies, and mutant spectra.
    Boerrigter ME
    Environ Mol Mutagen; 1999; 34(2-3):140-7. PubMed ID: 10529738
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mutant frequencies and spectra depend on growth state and passage number in cells cultured from transgenic lacZ-plasmid reporter mice.
    Busuttil RA; Rubio M; Dollé ME; Campisi J; Vijg J
    DNA Repair (Amst); 2006 Jan; 5(1):52-60. PubMed ID: 16126462
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of a plasmid-based transgenic mouse model for detecting in vivo mutations.
    Dollé ME; Martus HJ; Gossen JA; Boerrigter ME; Vijg J
    Mutagenesis; 1996 Jan; 11(1):111-8. PubMed ID: 8671725
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mutagenic activity of cisplatin in the lacZ plasmid-based transgenic mouse model.
    Louro H; Silva MJ; Boavida MG
    Environ Mol Mutagen; 2002; 40(4):283-91. PubMed ID: 12489119
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Plasmid-based transgenic mouse model for studying in vivo mutations.
    Boerrigter ME; Dollé ME; Martus HJ; Gossen JA; Vijg J
    Nature; 1995 Oct; 377(6550):657-9. PubMed ID: 7566182
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [In vivo micronuclei and gene mutation induced by DEN in the lacZ transgenic mouse].
    Zhan L; Zhang LS; Wang L; Zhu L; Zhang H; Suzuki T; Wu D
    Wei Sheng Yan Jiu; 2005 May; 34(3):269-71. PubMed ID: 16111025
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Quantitative correlation between radiation-induced mutagenesis in endogenous genes and transgenes of mouse spermatogonial stem cells.
    Martus HJ; Novak M; Blecher D; van Duyn-Goedhart A; Suter W; Gossen JA; van Buul PP
    Environ Mol Mutagen; 1999; 34(2-3):216-20. PubMed ID: 10529747
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nitrogen-substitution effect on in vivo mutagenicity of chrysene.
    Yamada K; Suzuki T; Kohara A; Kato TA; Hayashi M; Mizutani T; Saeki K
    Mutat Res; 2005 Sep; 586(1):1-17. PubMed ID: 16054434
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Detecting genotoxic effects of potential clastogens: an in vivo study using the transgenic lacZ plasmid and the MutaMouse model.
    Mahabir AG; van Benthem J; Korsten H; Lynch AM; Bailey L; de Vries A; Hendriksen CF; van Steeg H
    Mutat Res; 2008 Apr; 652(2):151-7. PubMed ID: 18387846
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 1,3-butadiene: cancer, mutations, and adducts. Part II: Roles of two metabolites of 1,3-butadiene in mediating its in vivo genotoxicity.
    Recio L; Saranko CJ; Steen AM
    Res Rep Health Eff Inst; 2000 Mar; (92):49-87; discussion 141-9. PubMed ID: 10925839
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vivo mutagenicity and hepatocarcinogenicity of 2-amino-3,8-dimethylimidazo[4,5-f]quinoxaline (MeIQx) in bitransgenic c-myc/lambda lacZ mice.
    Ryu DY; Pratt VS; Davis CD; Schut HA; Snyderwine EG
    Cancer Res; 1999 Jun; 59(11):2587-92. PubMed ID: 10363978
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reporter gene transgenic mice as a tool for analyzing the molecular mechanisms underlying experimental carcinogenesis.
    Nishikawa A; Suzuki T; Masumura K; Furukawa F; Miyauchi M; Nakamura H; Son HY; Nohmi T; Hayashi M; Hirose M
    J Exp Clin Cancer Res; 2001 Mar; 20(1):111-5. PubMed ID: 11370817
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mutation spectrum in UVB-exposed skin epidermis of a mildly-affected Xpg-deficient mouse.
    Wang F; Saito Y; Shiomi T; Yamada S; Ono T; Ikehata H
    Environ Mol Mutagen; 2006 Mar; 47(2):107-16. PubMed ID: 16247763
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Database and software for the analysis of mutations at the lacZ locus in transgenic rodents.
    Cariello NF; Douglas GR
    Environ Mol Mutagen; 1996; 28(2):145-53. PubMed ID: 8844996
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Frequency and spectrum of ENU-induced mutation in the Phi X174 transgene in mouse splenic lymphocytes and their significance to spontaneous transgenic rodent mutation frequencies.
    Valentine CR; Rainey HF; Farrell JM; Shaddock JG; Dobrovolsky VN; Delongchamp RR
    Mutagenesis; 2008 Sep; 23(5):383-97. PubMed ID: 18504270
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Studies on gene mutation and micronucleus formation induced by ethylnitrosourea (ENU) in transgenic mice in vivo].
    Cao J; Yin M; Chen J; Xu S
    Zhonghua Yu Fang Yi Xue Za Zhi; 2000 Jan; 34(1):28-30. PubMed ID: 11860893
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of heterozygous loss of p53 on benzo[a]pyrene-induced mutations and tumors in DNA repair-deficient XPA mice.
    van Oostrom CT; Boeve M; van Den Berg J; de Vries A; Dollé ME; Beems RB; van Kreijl CF; Vijg J; van Steeg H
    Environ Mol Mutagen; 1999; 34(2-3):124-30. PubMed ID: 10529736
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.